JSV Clinical Research Study, Inc.

Tampa, Florida 33634

1 studies enrolling now · 11 studies all time

What they study most

Atherosclerosis, Atherosclerotic Cardiovascular Disease, Cardiovascular Diseases, Hypertriglyceridemia, Migraine, Narcolepsy Type 1 (NT 1), Narcolepsy Type 1 (NT1), Narcolepsy Type 2 (NT2), OSA, Severe Hypertriglyceridemia

Studies at this site

• A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia — Completed
• CORE-OLE: A Study of Olezarsen (ISIS 678354) Administered Subcutaneously to Participants With Severe Hypertriglyceridemia (SHTG) — Running, not enrolling
• Parallel-Arm Study to Compare AD109 to Placebo With Patients With OSA (SynAIRgy Study) — Completed
• A Study of Olezarsen Administered Subcutaneously to Participants With Severe Hypertriglyceridemia — Completed
• Continuation Protocol for Obstructive Sleep Apnea (OSA) — Enrolling by invitation
• A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention — Stopped early
• A Study of TAK-994 in Adults With Type 1 and Type 2 Narcolepsy — Stopped early
• Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults — Completed
• Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease — Running, not enrolling
• A Study of TAK-994 in Adults With Narcolepsy — Stopped early
• Randomized Trial in Adult Participants With Acute Migraines — Completed